Concepedia

Nobuko Matsushima

NM

Statistics

Publications

15

Citations

1.2K

H-Index

13

Active since

1996

Affiliations

Daiichi-Sankyo (Japan)(Current)

Daiichi Sankyo (United States)

Daiichi Sankyo (Germany)

Eli Lilly (United States)

Janssen (United States)

Nobuko Matsushima is an author at Daiichi-Sankyo (Japan) specializing in pharmacology, clinical pharmacology, and pharmacy.

ORCID

Publications per year

1996–2024

15

Publications

15

Drug-Drug Interaction Studies of Cardiovascular Drugs Involving P-Glycoprotein, an Efflux Transporter, on the Pharmacokinetics of Edoxaban, an Oral Factor Xa Inhibitor

Jeanne Mendell, Hamim Zahir, Nobuko Matsushima et al. · American Journal of Cardiovascular Drugs · 2013 · 223 citations · Full text

, , +17

Bioavailability and Safety of the Factor Xa Inhibitor Edoxaban and the Effects of Quinidine in Healthy Subjects

Nobuko Matsushima, Frank Lee, Toshiyuki Sato et al. · Clinical Pharmacology in Drug Development · 2013 · 152 citations

, , +17

Three-Dimensional Structure of a DNA Repair Enzyme, 3-Methyladenine DNA Glycosylase II, from Escherichia coli

Yuriko Yamagata, Masato Kato, Kyoko Odawara et al. · Cell · 1996 · 137 citations · Full text

, , +11

Pharmacokinetics, safety, and tolerability of edoxaban in end-stage renal disease subjects undergoing haemodialysis

Thomas Marbury, Nobuko Matsushima, Shuquan Chen et al. · Thrombosis and Haemostasis · 2015 · 132 citations

, , +17

A multiple dose study of prasugrel (CS‐747), a novel thienopyridine P2Y<sub>12</sub> inhibitor, compared with clopidogrel in healthy humans

Joseph A. Jakubowski, Nobuko Matsushima, Fumitoshi Asai et al. · British Journal of Clinical Pharmacology · 2006 · 128 citations · Full text

, , +13

1–5 of 15